In this study, E2F1, E2F2, E2F3, and E2F5 were shown to be up-regulated in the malignant prostate tissue compared to the benign tissue, and their up-regulation was correlated with advanced stage and poor biochemical recurrence survival in PCa patients. The gene discussed is E2F5; the disease is posterior cortical atrophy.